Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit
EIN: 320422495 · Seattle, WA · NTEE: H40
| Metric | Value |
|---|---|
| Total Revenue | $1.6M |
| Total Expenses | $1.6M |
| Net Assets | $3.6M |
Is Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit
Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit (EIN: 320422495) is a nonprofit organization based in Seattle, WA, classified under NTEE code H40. The organization reported total revenue of $1.6M and total assets of $3.4M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit is a mid-size nonprofit that has been operating for 12 years, with 6 years of IRS 990 filings on record (2015–2023). Revenue has grown at a compound annual rate of 16.1%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $2.5M |
| Total Expenses | $1.6M |
| Surplus / Deficit | +$821K |
| Total Assets | $3.6M |
| Total Liabilities | $2K |
| Net Assets | $3.6M |
| Operating Margin | 33.3% |
| Debt-to-Asset Ratio | 0.0% |
| Months of Reserves | 26.4 months |
Financial Health Grade: A
In 2023, Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit reported a surplus of $821K with revenue exceeding expenses, holds 26.4 months of operating reserves (strong position), has a debt-to-asset ratio of 0.0% (very low leverage).
Financial Trends
Over 6 years of filings (2015–2023), Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit's revenue has grown at a compound annual growth rate (CAGR) of 16.1%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +77.4% | -2.4% | +28.6% |
| 2022 | -15.3% | +15.1% | -9.0% |
| 2021 | -33.8% | -1.6% | +6.3% |
| 2020 | +55.5% | +51.3% | +50.0% |
| 2019 | +113.7% | +155.0% | +237.4% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2800 |
| IRS Ruling Date | 2014 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $821K, with revenue exceeding expenses.
- Debt-to-asset ratio: 0.0%.
Frequently Asked Questions about Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit
Is Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit a legitimate charity?
Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit (EIN: 320422495) is a registered tax-exempt nonprofit based in Washington. It has 6 years of IRS 990 filings on record. Total revenue: $1.6M. No red flags identified. Financial health grade: A.
How does Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit spend its money?
Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit reported $1.6M in total revenue in IRS 990 filings. 6 years of filing data available. Revenue exceeded expenses in the most recent year. Review the full spending breakdown on NonprofitSpending.
Are donations to Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit tax-deductible?
Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit is registered as a tax-exempt nonprofit (EIN: 320422495). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit located?
Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit is headquartered in Seattle, Washington and files with the IRS under EIN 320422495. It is classified under NTEE code H40.
How many years of IRS 990 filings does Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit have?
Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit has 6 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $1.6M in total revenue.
Filing History
IRS 990 filing history for Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit showing financial trends over 6 years of public records:
Over 6 years of IRS 990 filings (2015–2023), Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit's revenue has grown by 230.5%, moving from $745K to $2.5M. Total assets increased by 528.9% over the same period, from $573K to $3.6M. Total functional expenses rose by 326.8%, from $385K to $1.6M. In its most recent filing year (2023), Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit reported a surplus of $821K, with revenue exceeding expenses. The organization holds $2K in liabilities against $3.6M in assets (debt-to-asset ratio: 0.0%), resulting in net assets of $3.6M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $2.5M | $1.6M | $3.6M | $2K | — | — |
| 2022 | $1.4M | $1.7M | $2.8M | $21K | — | View 990 |
| 2021 | $1.6M | $1.5M | $3.1M | $5K | — | View 990 |
| 2020 | $2.5M | $1.5M | $2.9M | $1K | — | View 990 |
| 2019 | $1.6M | $981K | $1.9M | $26K | — | View 990 |
| 2015 | $745K | $385K | $573K | $1 | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $2.5M, expenses of $1.6M, and assets of $3.6M (revenue +77.4% year-over-year).
- 2022: Revenue of $1.4M, expenses of $1.7M, and assets of $2.8M (revenue -15.3% year-over-year).
- 2021: Revenue of $1.6M, expenses of $1.5M, and assets of $3.1M (revenue -33.8% year-over-year).
- 2020: Revenue of $2.5M, expenses of $1.5M, and assets of $2.9M (revenue +55.5% year-over-year).
- 2019: Revenue of $1.6M, expenses of $981K, and assets of $1.9M (revenue +113.7% year-over-year).
- 2015: Revenue of $745K, expenses of $385K, and assets of $573K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit:
Data Sources and Methodology
This transparency report for Group For Research And Assessment Of Psoriasis And Psoriatic Arthrit is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.